ELOVL5 and prostate carcinoma: One study found that ELOVL5 deletion in prostate cancer significantly altered mitochondrial morphology and function, leading to overproduction of reactive oxygen species, which inhibited prostate cancer cell proliferation and metastasis, and conversely, supplementing the direct product of ELOVL5 extension could reverse this [64].